These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 5302938)
1. [Some clinical experiences with "Trasylol" in urological diseases]. Oda K; Oyama C; Mishina T; Miyatani K Hinyokika Kiyo; 1968 Feb; 14(2):165-9. PubMed ID: 5302938 [No Abstract] [Full Text] [Related]
2. [Local use of aprotinin in neurosurgical operations for the prevention of hyperfibrinolytic hemorrhage]. Giromini D; Tzonos T Fortschr Med; 1981 Aug; 99(29):1153-6. PubMed ID: 6167502 [TBL] [Abstract][Full Text] [Related]
3. [Use of trasylol in treatment of blood coagulation and fibrinoytic disorders in the light of experiences of the Department of Surgery, Institute of Hematology in Warsaw]. Zienkiewicz K Pol Tyg Lek; 1970 Oct; 25(41):1536-8. PubMed ID: 5312235 [No Abstract] [Full Text] [Related]
5. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436 [TBL] [Abstract][Full Text] [Related]
6. [The use of PAMBA in urology]. Hellinger J Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):187-96. PubMed ID: 4174658 [No Abstract] [Full Text] [Related]
7. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. Langdown AJ; Field J; Grote J; Himayat H J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196 [TBL] [Abstract][Full Text] [Related]
8. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867 [TBL] [Abstract][Full Text] [Related]
9. [Some clinical experiences of "DV-79 (trans-AMCHA)" in urological diseases]. Sugiura H Hinyokika Kiyo; 1966 Jan; 12(1):82-7. PubMed ID: 5950238 [No Abstract] [Full Text] [Related]
10. [Clinical findings on the effects of a new analgesic in urological pain syndromes]. Ferulano O; Merola L Minerva Anestesiol; 1969 May; 35():Suppl 5:6-19. PubMed ID: 5386664 [No Abstract] [Full Text] [Related]
11. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
12. [Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery. Comparison of tranexamic acid and high dose aprotinin]. Boughenou F; Madi-Jebara S; Massonnet-Castel S; Benmosbah L; Carpentier A; Cousin MT Arch Mal Coeur Vaiss; 1995 Mar; 88(3):363-70. PubMed ID: 7487290 [TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414 [TBL] [Abstract][Full Text] [Related]
15. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery. Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306 [TBL] [Abstract][Full Text] [Related]
16. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368 [TBL] [Abstract][Full Text] [Related]
17. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages. Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399 [TBL] [Abstract][Full Text] [Related]
18. Aprotinin use with hypothermic circulatory arrest for aortic valve and thoracic aortic surgery: renal function and early survival. Regragui IA; Bryan AJ; Izzat MB; Wisheart JD; Hutter JA; Angelini GD J Heart Valve Dis; 1995 Nov; 4(6):674-7. PubMed ID: 8611985 [TBL] [Abstract][Full Text] [Related]
19. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of aprotinin use for reoperative valvular surgery. Rodrigues AJ; Evora PR; Bassetto S; Luciano PM; Alves L; Filho AS; Vicente WV Ann Thorac Surg; 2007 Jun; 83(6):2060-5. PubMed ID: 17532397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]